Virtual Library

Start Your Search

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

Filter Results:

Show Only Available Presentations

  • +

    FP10 - Palliative and Supportive Care

    • Type: Posters (Featured)
    • Track: Palliative and Supportive Care
    • Presentations: 1
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      FP10.01 - The Efficacy of Immunotherapy in non-Small Cell Lung Cancer Patients with Uncommon Mutations: a Real World Research from Single Site

      00:00 - 00:00  |  Presenter: Ying Cheng

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P14 - Immunotherapy (Phase II/III Trials) - Clinical Trial in Progress

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 7
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P14.01 - Phase 3 Study of First-Line Pembrolizumab ± Vibostolimab (anti-TIGIT) in Patients With PD-L1‒Positive Metastatic NSCLC

      00:00 - 00:00  |  Presenter: Matthew D. Hellmann

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P17 - Immunotherapy (Phase II/III Trials) - First-Line, Advanced, Squamous NSCLC

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 3
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P17.01 - KEYNOTE-407 China Extension Final Analysis: Pembrolizumab Plus Chemotherapy for the Treatment of Metastatic Squamous NSCLC

      00:00 - 00:00  |  Presenter: Ying Cheng

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P19 - Immunotherapy (Phase II/III Trials) - Previously Treated NSCLC

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 2
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P19.01 - RATIONALE-303 Phase 3 Tislelizumab vs Docetaxel in Previously Treated Advanced NSCLC: China Subgroup Analysis

      00:00 - 00:00  |  Presenter: Yun Fan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 18
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P45.08 - Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China

      00:00 - 00:00  |  Presenter: Shun Lu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA02 - RET and Novel Combinations of Osimertinib

    • Type: Mini Oral
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 8
    • Coordinates: 9/08/2021, 09:30 - 10:30, Program Auditorium
    • +

      MA02.01 - Efficacy and Safety of Selpercatinib in Chinese Patients With RET Fusion-Positive Non-Small Cell Lung Cancer: A Phase 2 Trial

      09:30 - 09:35  |  Presenter: Shun Lu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA02.06 - Phase 1b Study of Pelcitoclax (APG-1252) in Combination With Osimertinib in Patients With EGFR TKI-Resistant NSCLC

      10:05 - 10:10  |  Presenter: Li Zhang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA09 - Expanding Immunotherapy Options for Non-Small Cell Lung Cancers

    • Type: Oral
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 5
    • Moderators:Rina Hui
    • Coordinates: 9/09/2021, 09:30 - 10:30, Program Auditorium
    • +

      OA09.03 - Pembrolizumab in Combination With Platinum-Based Chemotherapy in Recurrent EGFR/ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

      09:50 - 10:00  |  Presenter: Shirish M. Gadgeel

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    WS06 - Joint IASLC - CAALC - CSCO Workshop: Looking Toward the Future: Recognizing and Curing Lung Cancer

    • Type: Workshop
    • Track: N.A.
    • Presentations: 9
    • Moderators:Caicun Zhou
    • Coordinates: 9/11/2021, 22:15 - 23:45, Program Auditorium
    • +

      WS06.07 - Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China

      23:13 - 23:23  |  Presenter: Shun Lu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA15 - Upcoming Molecular Targeted Agents for EGFR exon 20 Insertion and MET Skipping Mutation

    • Type: Oral
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 6
    • Moderators:Helena A Yu
    • Coordinates: 9/12/2021, 18:45 - 19:45, Program Auditorium
    • +

      OA15.02 - Phase 1 Studies of DZD9008, an Oral Selective EGFR/HER2 Inhibitor in Advanced NSCLC with EGFR Exon20 Insertion Mutations

      18:55 - 19:05  |  Presenter: Pasi A. Janne

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA13 - Building on the Past: What Will Be the Next Immunotherapy Combination?

    • Type: Mini Oral
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 9
    • Coordinates: 9/13/2021, 17:30 - 18:30, Program Auditorium
    • +

      MA13.08 - CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC

      18:10 - 18:15  |  Presenter: Jie Wang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.